14 August 2013
: Case report
L-asparaginase fatal toxic encephalopathy during consolidation treatment in an adult with acute lymphoblastic leukemia
Unknown etiology, Unusual or unexpected effect of treatment, Unexpected drug reaction
Frantzeska FrantzeskakiABCDEFG, Michalis RizosABCD, Matilda PapathanassiouABC, Nikitas NikitasABC, Maria LerikouAB, Apostolos ArmaganidisAB, George DimopoulosABDOI: 10.12659/AJCR.889268
Am J Case Rep 2013; 14:311-314
Abstract
Background: Novel therapies have improved survival in malignancies of lymphoid origin. This improvement, however, has been at the cost of chemotherapy-related toxicities. L-asparaginase is frequently included in combination chemotherapies for acute lymphoblastic leukemia. Its use is frequently limited by significant adverse effects, such as coagulation abnormalities and cerebrovascular complications. L-asparaginase-associated encephalopathy is most often observed during the induction phase of chemotherapy and usually carries a favorable prognosis.
Case Report: We describe the profile of an adult with acute lymphoblastic leukemia treated with L-asparaginase, who developed toxic leukoencephalopathy during the second phase of consolidation treatment. He presented with decreased level of consciousness, which progressed to deep coma and finally brain death. MRI disclosed extensive lesions, consistent with toxic encephalopathy.
Conclusions: Even mild neurological symptoms should raise suspicion of these possibly fatal chemotherapy related toxicities.
Keywords: toxic encephalopathy, L-asparaginase, Leukemia
859 5
In Press
09 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939250
08 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939098
06 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940200
05 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939421
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250